New combo therapy shows promise in tough pancreatic cancer
NCT ID NCT04257448
First seen Sep 30, 2025 · Last updated Jun 06, 2026 · Updated 32 times
Summary
This study tested a new treatment plan for people with advanced pancreatic cancer that has spread. It combined chemotherapy with drugs that change how genes work and boost the immune system. The goal was to see if this approach is safe and can help control the disease. 75 patients took part in this early-phase trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Klinikum Nürnberg
Nuremberg, 90419, Germany
-
Ludwig-Maximilians-Universität München
München, 81377, Germany
-
Uniklinik Köln
Cologne, 50937, Germany
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Frankfurt
Frankfurt, 60590, Germany
-
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20251, Germany
-
Universitätsklinikum Ulm
Ulm, 89081, Germany
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
-
Universitätsmedizin Göttingen
Göttingen, 37075, Germany
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.